Tarsus Medical Group: Our Brands
Sign In
Join
Contact
  • About
  • Advisory Board
  • Partners
  • Contact
Menu
  • About
  • Advisory Board
  • Partners
  • Contact
  • Home
  • Industry News
    • Articles
    • Research
    • Blog
  • Focus Areas
    • Guidelines
    • Drug Pipelines
    • Parent & Patient Resources
    • Provider Resources
    • Accredited Continuing Education
  • Professional Education
    Professional Education
    Events

    7

    Online Education

    5

    Certification Courses

    4

    Business of Medicine

    5

    Continuing Education

    7

    Featured ARTICLES
    Pediatric Research
    MIS-C Diagnosed More Often in Black, Hispanic Children
    Masters Of Pediatrics July 14, 2021
    Latest RESEARCH & DATA
    MIS-C Diagnosed More Often in Black, Hispanic Children
    Researchers from The George Washington...
    FDA Says Children as Young as 3 Years Old can Take Epclusa for Hepatitis C
    Under an FDA-approved expansion of...
    Most Pediatric Rheumatology Providers Find Telehealth Lacking for Clinical Assessment
    In a recent survey, pediatric...
  • Career Development
    • Job Postings
    • Resident Resources
    • Certification Courses
  • Publications & Apps
    • Journals
    • Mobile Apps
    • Book Store
    • Podcasts
  • Find a Pediatrician

Day: October 26, 2020

How to Improve Health Outcomes for Infants Born with Neonatal Opioid Withdrawal Syndrome

​​​The U.S. opioid crisis has profoundly impacted pregnant mothers and infants. Mother and infant face considerable barriers to evidence-based treatment and care, which vary substantially

Masters of Pediatricsâ„¢ (MoP) is dedicated to the advancement of healthcare technologies and education serving as the academic home for child health professionals. Masters of Pediatrics offers continuing medical education, activities, and training through its advanced education entity Metabolic Medical Institute (MMI).
A division of Tarsus Medical owned by Tarsus Group
Professional Education
Events

7

Online Education

5

Certification Courses

4

Business of Medicine

5

Continuing Education

7

Latest Research

MIS-C Diagnosed More Often in Black, Hispanic Children

FDA Says Children as Young as 3 Years Old can Take Epclusa for Hepatitis C

About

+1 (888) 555-1212

Copyright © 2022, A4M. All trademarks, registered or unregistered, are the property of their respective owners.

Top
Menu
  • Home
  • Industry News
    • Articles
    • Research
    • Blog
  • Focus Areas
    • Guidelines
    • Drug Pipelines
    • Parent & Patient Resources
    • Provider Resources
    • Accredited Continuing Education
  • Professional Education
    • Events
    • Online Education
    • Certification Courses
    • Business of Medicine
  • Career Development
    • Job Postings
    • Resident Resources
    • Certification Courses
  • Publications & Apps
    • Journals
    • Mobile Apps
    • Book Store
    • Podcasts
  • Find a Pediatrician
START HERE
  • Industry News
  • Professional Education
  • Career Development
  • Publications & Apps
MEMBERSHIP
  • Join Masters of Pediatrics
  • Advantages of Membership
  • Directory
Latest RESEARCH & DATA
Pediatric Research
MIS-C Diagnosed More Often in Black, Hispanic Children
July 14, 2021
Pediatric News
FDA Says Children as Young as 3 Years Old can Take Epclusa for Hepatitis C
July 9, 2021